Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study.
Lin YS, Yang H, Li XY, Wu LQ, Xu JG, Yang AM, Gao ZR, Ding Y, Zhang YQ, Chen K, Mu ZZ, Jia JM, Niu N, Sun D, Zhang X, Zhang SQ, Geng QQ, Zhang YJ, Chen FN, He BX.
Lin YS, et al.
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4171-4181. doi: 10.1007/s00259-022-05865-y. Epub 2022 Jul 4.
Eur J Nucl Med Mol Imaging. 2022.
PMID: 35781600
Clinical Trial.